Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.

• Asıl Yazarlar: Cynthia Sung (Yazar), Yuan Wei (Yazar), Satoru Watanabe (Yazar), How Sung Lee (Yazar), Yok Moi Khoo (Yazar), Lu Fan (Yazar), Abhay P S Rathore (Yazar), Kitti Wing-Ki Chan (Yazar), Milly M Choy (Yazar), Uma S Kamaraj (Yazar), October M Sessions (Yazar), Pauline Aw (Yazar), Paola F de Sessions (Yazar), Bernett Lee (Yazar), John E Connolly (Yazar), Martin L Hibberd (Yazar), Dhanasekaran Vijaykrishna (Yazar), Limin Wijaya (Yazar), Eng Eong Ooi (Yazar), Jenny Guek-Hong Low (Yazar), Subhash G Vasudevan (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Public Library of Science (PLoS), 2016-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

UNLABELLED:CELADEN was a randomized placebo-controlled trial of 50 patients with confirmed dengue fever to evaluate the efficacy and safety of celgosivir (A study registered at ClinicalTrials.gov, number NCT01619969). Celgosivir was given as a 400 mg loading dose and 200 mg bid (twice a day) over 5...